🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Quasi-experimental intervention multicenter trial of patients treated with ...
Status
Unknown
Location
Hospital de Poniente-El Ejido
Start Date
2019-07-09
Trial ID
NCT03941951
Treatments Being Tested
This study will compare dalbavancin to standard of care (SOC) antibiotic th...
Status
Terminated
Location
Midway Immunology and Research Center
Start Date
2017-05-12
Trial ID
NCT03148756
Treatments Being Tested
The purpose of this study is to evaluate the Pharmacokinetic (PK) profile o...
Status
Terminated
Location
Mary Birch Hospital for Women and Newborns
Start Date
2016-04-01
Trial ID
NCT02688790
Treatments Being Tested
This is a Phase 2b clinical study, multicenter, randomized, open-label, ass...
Status
Completed
Location
University of Alabama Hospital - Infectious Diseases
Start Date
2021-04-22
Trial ID
NCT04775953
Treatments Being Tested
This study will evaluate a new critical pathway (use of guideline-based pat...
Status
Completed
Location
Maricopa Medical Center
Start Date
2016-11-29
Trial ID
NCT02961764
Treatments Being Tested
This clinical study will be a multi-center, randomized, open-label, active-...
Status
Terminated
Location
Midway Immunology and Research Center
Start Date
2017-05-15
Trial ID
NCT03091439
Treatments Being Tested
Gram-positive cocci, particularly Staphylococcus aureus and coagulase-negat...
Status
Active Not Recruiting
Location
Nîmes University Hospital
Start Date
2024-01-01
Trial ID
NCT06688084
Treatments Being Tested
Adolescent subjects hospitalized for the treatment of bacterial infections ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-09
Trial ID
NCT00678106
Treatments Being Tested
Dalbavancin for Pediatric Osteomyelitis...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-03
Trial ID
NCT02344511
Treatments Being Tested
This study evaluates the use of Dalbavancin 1500 mg IV x 1 dose for treatin...
Status
Terminated
Location
University of Colorado Hospital
Start Date
2020-06-01
Trial ID
NCT04624451
Treatments Being Tested